Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$78.71

0.06 (0.08%)

09:10
04/25/19
04/25
09:10
04/25/19
09:10

AbbVie says seeing strong momentum across all aspects of organization

Says: Late stage pipeline continues to deliver... Well-positioned to deliver double digit earnings growth in 2019... Making significant progress in developing pipeline. Comments from Q1 earnings conference call.

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV AbbVie
$78.71

0.06 (0.08%)

03/25/19
ARGS
03/25/19
DOWNGRADE
ARGS
Hold
AbbVie downgraded to Hold from Buy at Argus
03/25/19
03/25/19
DOWNGRADE

Hold
AbbVie downgraded to Hold from Buy at Argus
As previously reported, Argus analyst David Toung downgraded AbbVie to Hold, saying its flagship program Humira "no longer looks invulnerable to competition from biosimilars in Europe and other overseas markets." The analyst notes that Humira is also faced with "indirect competition from newer drugs that have an alternative mechanism of action" compared to Humira's anti-TNF class. Toung further cites AbbVie's clinical setback with Venclexta, which highlights the risks for the company as it develops a pipeline aimed to offset the expected decline in Humira sales.
03/26/19
WBLR
03/26/19
UPGRADE
WBLR
Outperform
William Blair upgrades Vertex to Outperform after 'subpar' competitor data
William Blair analyst Y. Katherine Xu upgraded Vertex Pharmaceuticals (VRTX) to Outperform from Market Perform on expectations the company's cystic fibrosis franchise will continue dominating after Proteostasis (PTI) reported disappointing triplet data. Proteostasis' triplet efficacy falls short of the high bar set by the Vertex triples, Xu tells investors in a research note. While Proteostasis is starting a Phase II study of the triplet that would include a higher PTI-808 dose and test a longer duration aiming to optimize response with data out around year-end 2019, the chance of it matching or exceeding Vertex triple efficacy is "very low," contends the analyst. With both Galapagos (GLPG)/AbbVie (ABB) and Proteostasis having shown "subpar data," Xu is upgrading Vertex shares to Outperform and raised her fair value estimate for the shares to $222 from $178. The analyst maintains her high probability of success of a Vertex triple combo reaching the cystic fibrosis market at 90% and ascribe peak sales of $10.2B, up from $8.9 billion previously.
04/11/19
EVER
04/11/19
INITIATION
Target $30
EVER
Outperform
Myovant Sciences initiated with an Outperform at Evercore ISI
Evercore ISI analyst Ravi Mehrotra initiated Myovant Sciences (MYOV) with an Outperform rating and a price targets of $30. The analyst says the company's lead program relugolix has been clinically de-risked with near-term pivotal data readouts. Mehrotra is modeling revenues of $944M for the program by 2023 thanks to its "commercial advantage of a one-a-day pill" and the "second-mover leverage of competitor AbbVie's (ABBV) efforts to raise awareness and diagnosis" in woman's health market.

TODAY'S FREE FLY STORIES

02:50
06/25/19
06/25
02:50
06/25/19
02:50
General news
FX Update: The dollar hit fresh lows against the euro and yen »

FX Update: The dollar hit…

02:00
06/25/19
06/25
02:00
06/25/19
02:00
General news
Asian Market Wrap: »

Asian Market Wrap: 10…

GLOG

GasLog

$13.13

-0.23 (-1.72%)

, GLOP

GasLog Partners

$21.12

-0.37 (-1.72%)

23:10
06/24/19
06/24
23:10
06/24/19
23:10
Upgrade
GasLog, GasLog Partners rating change at Stifel »

GasLog upgraded to Buy…

GLOG

GasLog

$13.13

-0.23 (-1.72%)

GLOP

GasLog Partners

$21.12

-0.37 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOP

GasLog Partners

$21.12

-0.37 (-1.72%)

, GLOG

GasLog

$13.13

-0.23 (-1.72%)

23:05
06/24/19
06/24
23:05
06/24/19
23:05
Downgrade
GasLog Partners, GasLog rating change at Stifel »

GasLog Partners…

GLOP

GasLog Partners

$21.12

-0.37 (-1.72%)

GLOG

GasLog

$13.13

-0.23 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$55.76

0.13 (0.23%)

20:40
06/24/19
06/24
20:40
06/24/19
20:40
Downgrade
Kellogg rating change at Consumer Edge »

Kellogg downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$41.15

11.87 (40.54%)

20:39
06/24/19
06/24
20:39
06/24/19
20:39
Syndicate
Krystal Biotech 2.5M share Spot Secondary priced at $40.00 »

Goldman Sachs and Cowen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

FDS

FactSet

$293.20

-4.89 (-1.64%)

, LEN

Lennar

$51.41

0.09 (0.18%)

20:25
06/24/19
06/24
20:25
06/24/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FDS

FactSet

$293.20

-4.89 (-1.64%)

LEN

Lennar

$51.41

0.09 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

, GMDA

Gamida Cell

$7.21

-0.23 (-3.09%)

19:33
06/24/19
06/24
19:33
06/24/19
19:33
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Genfit (GNFT), up…

GNFT

Genfit

$20.19

-0.02 (-0.10%)

GMDA

Gamida Cell

$7.21

-0.23 (-3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

CGC

Canopy Growth

$40.51

0.31 (0.77%)

19:20
06/24/19
06/24
19:20
06/24/19
19:20
Periodicals
Canopy Growth CEO says done buying other producers, Reuters says »

Canopy Growth CEO Bruce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWK

American Water

$118.43

0.4 (0.34%)

19:18
06/24/19
06/24
19:18
06/24/19
19:18
Hot Stocks
Illinois American Water investing over $1.8M in Farmington Water System »

Illinois American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

19:14
06/24/19
06/24
19:14
06/24/19
19:14
Periodicals
U.K.'s new F35 stealth aircraft used on operations, Telegraph says »

The U.K.'s new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$68.86

-0.53 (-0.76%)

19:01
06/24/19
06/24
19:01
06/24/19
19:01
Hot Stocks
Gilead, Carna Biosciences announce research and development collaboration »

Gilead and Carna…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$374.10

2.14 (0.58%)

18:59
06/24/19
06/24
18:59
06/24/19
18:59
Hot Stocks
Boeing CEO approves quarterly dividend »

Boeing Chairman,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

, GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

18:09
06/24/19
06/24
18:09
06/24/19
18:09
Periodicals
Google tells workers Pride protests are against code of conduct, Verge says »

According to internal…

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

AAPL

Apple

$198.60

-0.17 (-0.09%)

17:53
06/24/19
06/24
17:53
06/24/19
17:53
Hot Stocks
Apple to add 2,000 employees in Seattle over next 5 years »

Seattle mayor Jenny A.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$111.25

0.08 (0.07%)

, FB

Facebook

$192.56

1.4 (0.73%)

17:51
06/24/19
06/24
17:51
06/24/19
17:51
Periodicals
Walmart in Mexico rolls out grocery delivery via WhatsApp, Reuters says »

Walmart's (WMT)…

WMT

Walmart

$111.25

0.08 (0.07%)

FB

Facebook

$192.56

1.4 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

  • 15

    Aug

  • 13

    Nov

CAT

Caterpillar

$134.37

0.43 (0.32%)

17:46
06/24/19
06/24
17:46
06/24/19
17:46
Hot Stocks
Caterpillar awarded share of $900M Defense Logistics Agency contract »

Caterpillar is sharing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$35.14

0.06 (0.17%)

17:45
06/24/19
06/24
17:45
06/24/19
17:45
Hot Stocks
FB Financial provides update on its exit of wholesale mortgage channels »

FB Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$31.11

-0.99 (-3.08%)

17:44
06/24/19
06/24
17:44
06/24/19
17:44
Hot Stocks
Fluor: Stork consortium awarded four-year agreement by Ecopetrol in Colombia »

Fluor announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERYP

Erytech Pharma

$6.69

(0.00%)

17:33
06/24/19
06/24
17:33
06/24/19
17:33
Hot Stocks
Erytech Pharma announces strategic collaboration with SQZ Biotechnologies »

ERYTECH Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

17:33
06/24/19
06/24
17:33
06/24/19
17:33
Hot Stocks
Lockheed Martin awarded $561.80M Army contract »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$35.38

-1.01 (-2.78%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30
Syndicate
The Medicines Co. files to sell $150M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHTLY

Metcash

$0.00

(0.00%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30
Downgrade
Metcash rating change at Goldman Sachs »

Metcash downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:28
06/24/19
06/24
17:28
06/24/19
17:28
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

AAXN

Axon

$73.22

-0.12 (-0.16%)

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

HRS

Harris

$197.28

-0.07 (-0.04%)

USNA

Usana

$72.41

-0.58 (-0.79%)

LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

ABCB

Ameris Bancorp

$37.76

(0.00%)

XNCR

Xencor

$33.86

-1.31 (-3.72%)

HF

HFF Inc.

$45.25

-0.29 (-0.64%)

JLL

Jones Lang LaSalle

$137.43

-2.075 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 06

    Aug

  • 26

    Aug

TMSR

TMSR Holding

$1.67

(0.00%)

17:28
06/24/19
06/24
17:28
06/24/19
17:28
Syndicate
Breaking Syndicate news story on TMSR Holding »

TMSR Holding files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.